BeyondSpring Overview
DCF fair value estimate for BeyondSpring: $0.18.
Get informed when a big investor buys or sells
+ Follow$0.18
Overvalued by 75.0% based on the discounted cash flow analysis.
BeyondSpring (BYSI) currently reports a DCF fair value of $0.18. Use the charts on this page to explore BeyondSpring's DCF fair value history and peer comparisons.
BeyondSpring's discounted cash flow (DCF) fair value estimate is $0.18, about 75.0% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $0.18, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BeyondSpring, and consider following BYSI for alerts when major investors trade the stock.
BeyondSpring is classified in the Healthcare sector. On DCF fair value, it currently shows $0.18. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BYSI with unrelated industries.
